The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone

OBJECTIVE: This 24-week trial assessed the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes with inadequate glycemic control with metformin alone. RESEARCH DESIGN AND METHODS: This was a randomized, double-blind, placebo-controlled study of saxagliptin (2.5, 5, o...

Descripción completa

Detalles Bibliográficos
Autores principales: DeFronzo, Ralph A., Hissa, Miguel N., Garber, Alan J., Luiz Gross, Jorge, Yuyan Duan, Raina, Ravichandran, Shoba, Chen, Roland S.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732156/
https://www.ncbi.nlm.nih.gov/pubmed/19478198
http://dx.doi.org/10.2337/dc08-1984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732156/
https://www.ncbi.nlm.nih.gov/pubmed/19478198
http://dx.doi.org/10.2337/dc08-1984

Ejemplares similares